Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
46 studies found for:    "Hypoparathyroidism"
Show Display Options
Rank Status Study
21 Active, not recruiting Parathyroid and Thymus Transplantation in DiGeorge #931
Conditions: DiGeorge Syndrome;   Hypoparathyroidism;   Complete DiGeorge Syndrome
Intervention: Biological: Thymus/Parathyroid Transplantation
22 Completed Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects
Conditions: Hypoparathyroidism;   Tetralogy of Fallot;   Pulmonary Valve Stenosis;   Conotruncal Cardiac Defects;   Heart Defects, Congenital;   Pulmonary Atresia
Interventions: Drug: calcium gluconate;   Drug: sodium citrate
23 Completed
Has Results
Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
Conditions: Osteoporosis;   Osteopenia;   Vitamin D Deficiency;   Hypoparathyroidism;   Hypercalciuria;   Hypercalcemia
Intervention: Drug: Vitamin D
24 Active, not recruiting Phase I/II Thymus Transplantation With Immunosuppression #950
Conditions: DiGeorge Anomaly;   Complete DiGeorge Anomaly;   Complete Atypical DiGeorge Anomaly;   Complete DiGeorge Syndrome;   Complete Atypical DiGeorge Syndrome
Interventions: Biological: Thymus Tissue for Transplantation;   Other: Thymus Tissue and Parental Parathyroid Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Daclizumab;   Drug: Mycophenolate mofetil
25 Active, not recruiting Thymus Transplantation Dose in DiGeorge #932
Conditions: DiGeorge Anomaly;   DiGeorge Syndrome;   Complete DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus Tissue for Transplantation;   Other: Parathyroid Tissue for Transplantation
26 Unknown  The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
Conditions: Velocardiofacial Syndrome;   Williams Syndrome;   Fragile X Syndrome
Intervention: Drug: methylphenidate, fluoxetin, risperidone
27 Completed Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
Conditions: Williams Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   Shprintzen Syndrome;   Smith-Magenis Syndrome;   DiGeorge Syndrome;   Chromosome Abnormalities
Intervention:
28 Active, not recruiting Computerized Cognitive Skills Training for Adolescents With Velocardiofacial Syndrome
Condition: Velocardiofacial Syndrome
Intervention: Behavioral: Challenging Our Minds Program
29 Completed Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study
Conditions: DiGeorge Syndrome;   Velocardiofacial Syndrome;   22q11.2 Syndrome
Intervention:
30 Terminated Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome
Conditions: Velo-cardio-facial Syndrome;   Psychosis
Interventions: Drug: Metyrosine;   Drug: Placebo
31 Terminated Serum-Free Thymus Transplantation in DiGeorge Anomaly
Condition: DiGeorge Anomaly
Interventions: Biological: Serum Free Thymus Transplantation with Immunosuppression;   Other: Serum Free Thymus Transplantation without immunosuppression
32 Recruiting Thymus Transplantation Safety-Efficacy
Conditions: Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus  Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil
33 Unknown  Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
Conditions: DiGeorge Syndrome;   Shprintzen Syndrome;   Chromosome Abnormalities;   Abnormalities, Multiple;   Conotruncal Cardiac Defects
Intervention:
34 Terminated Infection in DiGeorge Following CHD Surgery
Conditions: DiGeorge Syndrome;   Congenital Heart Defects
Intervention:
35 Not yet recruiting Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo
36 Unknown  Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Conditions: DiGeorge Syndrome;   22q11.2 Deletion Syndrome
Intervention:
37 Unknown  Genetics and Psychopathology in the 22q11 Deletion Syndrome
Condition: Chromosome 22q11.2 Deletion Syndrome
Intervention:
38 Active, not recruiting Thymus Transplantation With Immunosuppression
Conditions: DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Anomaly;   Complete DiGeorge Syndrome
Intervention: Biological: Thymus Tissue for Transplantation
39 Completed Middle and Inner Ear Malformation in Children With Velocardiofacial Syndrome
Condition: Ear Malformations in the Velocardiofacial Syndrome
Intervention:
40 Recruiting Immune Disorder HSCT Protocol
Conditions: Immune Deficiency Disorders:;   Severe Combined Immunodeficiency;   Chronic Granulomatous Disease;   X-linked Agammaglobulinemia;   Wiskott-Aldrich Syndrome;   Hyper-IgM;   DiGeorge Syndrome;   Chediak-Higashi Syndrome;   Common Variable Immune Deficiency;   Immune Dysregulatory Disorder:;   Hemophagocytic Lymphohistiocytosis;   IPEX;   Autoimmune Lymphoproliferative Syndrome;   X-linked Lymphoproliferative Syndrome
Intervention: Drug: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results    Last Page
Indicates status has not been verified in more than two years